Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global ...

Piramal Pharma Ltd has more than tripled investor wealth since 2023-24. With the Mumbai-based drug development and manufacturing company turning around its business recently, its stock has ...

Piramal Pharma anticipates muted, single-digit growth for its contract development and manufacturing organization (CDMO) business in FY26, hurt by near-term uncertainties as clients defer ...

There’s a lot to memorize these days. But even making a fuzzy note in your brain of changes to major services can help you ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Responding to what it called a trend toward United States onshoring of drug supply, Mumbai-based Piramal Pharma announced an investment plan worth $90 million, developed in conjunction with the 2025 ...

MUMBAI, India, May 12, 2025 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, in conjunction with the 2025 SelectUSA Investment ...

Addition of commercial-scale sterile injectables capabilities in Lexington, KY Addition of development and commercial-scale capabilities in payload-linkers for bioconjugates in Riverview, MI This is ...

The total consideration paid by the Piramal Group of ~INR 34,250 Crores at the completion of the acquisition, includes an upfront cash component of ~INR 14,700 Crores and issuance of debt ...

Google’s logo just got a little bit blurrier. In a new logo quietly rolled out across iOS and Pixel, the search giant ditches its color-blocked “G” for gradients. Google’s new logo keeps ...